Gastón Bergero

Dr. Gastón Bergero


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2022 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
NENatalia Eberhardt
Natalia Eberhardt
GBGastón Bergero
Gastón Bergero
YMYanina L. Mazzocco Mariotta
Yanina L. Mazzocco Mariotta
MAMaria Pilar Aoki
Maria Pilar Aoki

13 May 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
GBGastón Bergero
Gastón Bergero
YMYanina L. Mazzocco
Yanina L. Mazzocco
Sebastian Del RossoSebastian Del Rosso
Sebastian Del Rosso
RLRuining Liu
Ruining Liu
ZGZoé M. Cejas Gallardo
Zoé M. Cejas Gallardo
MAMaria Pilar Aoki
Maria Pilar Aoki
Chagas disease, caused by Trypanosoma cruzi , is endemic to Latin America and is characterized by chronic inflammation of cardiac tissues due to parasite persistence. Hypoxia within infected tissues may trigger the stabilization of HIF-1 and be linked to ATP release. Extracellular ATP exhibits microbicidal effects but is scavenged by CD39 and CD73 ectonucleotidases, which ultimately generate adenosine (ADO), a potent immunosuppressor. Here, we comprehensively study the importance of HIF-1 stabilization and the CD39/CD73/ADO axis, on CD4 + T cells with the cytotoxic phenotype, in facilitating the persistence of T. cruzi . Myocardial infection induces prominent areas of hypoxia, which is concomitant with HIF-1α stabilization in T cells and linked to early expansion of CD39 + CD73 + CD4 + T cell infiltrating population. Functional assays further demonstrate that HIF-1 stabilization and CD73 activity are associated with impaired CD4 + T cell cytotoxic potential. RNA-Seq analysis reveals that HIF-1 and purinergic signaling pathways are overrepresented in cardiac tissues of patients with end-stage Chagas disease. The findings highlight a major effect of purinergic signaling on CD4 + T cells with potential cytotoxic capacity in the setting of T. cruzi infection and have translational implications for therapy.